Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio F Mata

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Trends in Neurosciences|April 18, 2006
LRRK2 in Parkinson's disease: protein domains and functional insightsIgnacio F Mata, William J Wedemeyer, Matthew J Farrer, et al.
Journal of Human Genetics|April 25, 2014
The screening of the 3'UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's diseaseLucía F Cardo, Eliecer Coto, René Ribacoba, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Comprehensive genetic screening of the South African Parkinson's disease study collection using the NeuroBooster arrayKathryn Step, Lusanda Madula, Nicole Kuznetsov, et al.
American Journal of Medical Genetics|July 13, 2002
Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer diseaseVictoria Alvarez, Ignacio F Mata, Pelayo González, et al.
CNS Drugs|April 7, 2024
Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart ReviewAmira Salim, Elise Hennessy, Claire Sonneborn, et al.
Plos Genetics|March 9, 2026
Polygenic risk scores and Parkinson's disease in South Africa advancing ancestry informed disease predictionKathryn Step, Carene Anne Alene Ndong Sima, Spencer Grant, et al.
Neurology. Clinical Practice|October 14, 2024
Efficacy and Tolerability of Anti-CGRP Monoclonal Antibodies in Patients Aged ≥ 65 Years With Daily or Nondaily MigraineAmira Salim, Sudipa Biswas, Claire Sonneborn, et al.
Movement Disorders Clinical Practice|January 26, 2023
Gender Differences in the Prevalence of Parkinson's DiseaseAlexandra Zirra, Shilpa C Rao, Jonathan Bestwick, et al.
Neuroscience Letters|January 15, 2014
Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphismsLucía F Cardo, Eliecer Coto, Lorena de Mena, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Polygenic risk scores and Parkinson's disease in South Africa: Moving towards ancestry-informed disease predictionKathryn Step, Carene Anne Alene Ndong Sima, Spencer Grant, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Trends in Neurosciences|April 18, 2006
LRRK2 in Parkinson's disease: protein domains and functional insightsIgnacio F Mata, William J Wedemeyer, Matthew J Farrer, et al.
Journal of Human Genetics|April 25, 2014
The screening of the 3'UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's diseaseLucía F Cardo, Eliecer Coto, René Ribacoba, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Comprehensive genetic screening of the South African Parkinson's disease study collection using the NeuroBooster arrayKathryn Step, Lusanda Madula, Nicole Kuznetsov, et al.
American Journal of Medical Genetics|July 13, 2002
Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer diseaseVictoria Alvarez, Ignacio F Mata, Pelayo González, et al.
CNS Drugs|April 7, 2024
Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart ReviewAmira Salim, Elise Hennessy, Claire Sonneborn, et al.
Plos Genetics|March 9, 2026
Polygenic risk scores and Parkinson's disease in South Africa advancing ancestry informed disease predictionKathryn Step, Carene Anne Alene Ndong Sima, Spencer Grant, et al.
Neurology. Clinical Practice|October 14, 2024
Efficacy and Tolerability of Anti-CGRP Monoclonal Antibodies in Patients Aged ≥ 65 Years With Daily or Nondaily MigraineAmira Salim, Sudipa Biswas, Claire Sonneborn, et al.
Movement Disorders Clinical Practice|January 26, 2023
Gender Differences in the Prevalence of Parkinson's DiseaseAlexandra Zirra, Shilpa C Rao, Jonathan Bestwick, et al.
Neuroscience Letters|January 15, 2014
Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphismsLucía F Cardo, Eliecer Coto, Lorena de Mena, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Polygenic risk scores and Parkinson's disease in South Africa: Moving towards ancestry-informed disease predictionKathryn Step, Carene Anne Alene Ndong Sima, Spencer Grant, et al.
Pageof 13